LLY

933.6

-0.49%↓

JNJ

186.56

+0.16%↑

UNH

323.45

-0.98%↓

NVS

126.48

+0.85%↑

ABT

124.47

+0.08%↑

LLY

933.6

-0.49%↓

JNJ

186.56

+0.16%↑

UNH

323.45

-0.98%↓

NVS

126.48

+0.85%↑

ABT

124.47

+0.08%↑

LLY

933.6

-0.49%↓

JNJ

186.56

+0.16%↑

UNH

323.45

-0.98%↓

NVS

126.48

+0.85%↑

ABT

124.47

+0.08%↑

LLY

933.6

-0.49%↓

JNJ

186.56

+0.16%↑

UNH

323.45

-0.98%↓

NVS

126.48

+0.85%↑

ABT

124.47

+0.08%↑

LLY

933.6

-0.49%↓

JNJ

186.56

+0.16%↑

UNH

323.45

-0.98%↓

NVS

126.48

+0.85%↑

ABT

124.47

+0.08%↑

Search

Treace Medical Concepts Inc

Abierto

6.15 -3.15

Resumen

Variación precio

24h

Actual

Mínimo

5.93

Máximo

6.39

Métricas clave

By Trading Economics

Ingresos

-1.5M

-17M

Ventas

-5.2M

47M

Margen de beneficio

-36.715

Empleados

477

EBITDA

-1.4M

-14M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+29.14% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

63M

416M

Apertura anterior

9.3

Cierre anterior

6.15

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Treace Medical Concepts Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

5 nov 2025, 23:51 UTC

Ganancias

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 nov 2025, 23:10 UTC

Ganancias

DBS Third Quarter Net Dips 2.0%

5 nov 2025, 22:55 UTC

Ganancias

Arm Holdings 2Q Profit Climbs on Record Demand

5 nov 2025, 22:23 UTC

Ganancias

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 nov 2025, 23:52 UTC

Ganancias

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 nov 2025, 23:49 UTC

Ganancias

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 nov 2025, 23:49 UTC

Ganancias

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 nov 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 nov 2025, 23:42 UTC

Charlas de Mercado

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 nov 2025, 23:12 UTC

Ganancias

Nutrien 3Q Adj EPS 97c >NTR.T

5 nov 2025, 23:11 UTC

Ganancias

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 nov 2025, 23:10 UTC

Ganancias

Nutrien 3Q Sales $6.01B >NTR.T

5 nov 2025, 23:10 UTC

Charlas de Mercado
Ganancias

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 nov 2025, 23:10 UTC

Ganancias

Nutrien 3Q EPS 96c >NTR.T

5 nov 2025, 23:04 UTC

Ganancias

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 nov 2025, 23:03 UTC

Charlas de Mercado

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 nov 2025, 22:55 UTC

Charlas de Mercado

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 nov 2025, 22:55 UTC

Ganancias

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 nov 2025, 22:51 UTC

Ganancias

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 nov 2025, 22:50 UTC

Ganancias

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 nov 2025, 22:44 UTC

Adquisiciones, fusiones, absorciones

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov 2025, 22:43 UTC

Charlas de Mercado
Ganancias

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 nov 2025, 22:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 nov 2025, 22:36 UTC

Charlas de Mercado

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 nov 2025, 22:20 UTC

Charlas de Mercado

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 nov 2025, 22:12 UTC

Adquisiciones, fusiones, absorciones

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

Pfizer Responds to Delaware Chancery Court Ruling

5 nov 2025, 22:01 UTC

Ganancias

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 nov 2025, 22:01 UTC

Ganancias

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Comparación entre iguales

Cambio de precio

Treace Medical Concepts Inc Esperado

Precio Objetivo

By TipRanks

29.14% repunte

Estimación a 12 meses

Media 8.42 USD  29.14%

Máximo 12 USD

Mínimo 6 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Treace Medical Concepts Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

2

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

7.16 / 7.65Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat